U.S. Physical Therapy (NYSE:USPH) released its earnings results on Thursday. The company reported $0.71 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.71, Fidelity Earnings reports. U.S. Physical Therapy had a net margin of 6.22% and a return on equity of 19.19%. The firm had revenue of $117.30 million during the quarter, compared to analysts’ expectations of $121.28 million. During the same period in the previous year, the company earned $0.64 EPS. U.S. Physical Therapy’s revenue for the quarter was up 3.7% on a year-over-year basis. U.S. Physical Therapy updated its FY19 guidance to $2.80-2.90 EPS.
Shares of NYSE USPH traded down $1.68 during trading on Friday, hitting $117.50. 188,815 shares of the company traded hands, compared to its average volume of 87,569. U.S. Physical Therapy has a 1 year low of $98.69 and a 1 year high of $148.48. The company has a 50-day moving average price of $134.71 and a 200-day moving average price of $126.55. The firm has a market capitalization of $1.86 billion, a P/E ratio of 44.34, a P/E/G ratio of 4.05 and a beta of 1.09. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.53.
The business also recently disclosed a dividend, which will be paid on Friday, December 13th. Stockholders of record on Monday, November 18th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio is presently 45.28%.
Several analysts have recently issued reports on the stock. Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 price objective for the company in a research note on Friday. ValuEngine raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research note on Friday, November 1st. Finally, Zacks Investment Research reissued a “hold” rating on shares of U.S. Physical Therapy in a research note on Saturday, October 19th. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $127.20.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Recommended Story: Street Name
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.